TMEM134
Transmembrane protein 134
Also known as: FLJ21749, TM134_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6X4
- Gene
- TMEM134
- Ensembl
- ENSG00000172663
- Chromosome
- 11
- Canonical length
- 195 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
195 residues, UniProt reviewed canonical sequence.
>Q9H6X4|TMEM134
1 MSAARPQFSI DDAFELSLED GGPGPESSGV ARFGPLHFER RARFEVADED KQSRLRYQNL
61 ENDEDGAQAS PEPDGGVGTR DSSRTSIRSS QWSFSTISSS TQRSYNTCCS WTQHPLIQKN
121 RRVVLASFLL LLLGLVLILV GVGLEATPSP GVSSAIFFVP GFLLLVPGVY HVIFIYCAVK
181 GHRGFQFFYL PYFEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM134 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 57 nTPM
- skin: 56 nTPM
- esophagus: 55 nTPM
- heart muscle: 46 nTPM
- pancreas: 42 nTPM
- liver: 34 nTPM
Single-cell type
- esophageal apical cells: 873 nCPM
- esophageal suprabasal cells: 584 nCPM
- esophageal basal cells: 296 nCPM
- suprabasal keratinocytes: 230 nCPM
- extravillous trophoblasts: 219 nCPM
- epididymal principal cells: 213 nCPM
Immune cell
- memory B-cell: 205 nTPM
- naive B-cell: 197 nTPM
- non-classical monocyte: 177 nTPM
- intermediate monocyte: 133 nTPM
- T-reg: 124 nTPM
- eosinophil: 99 nTPM
Brain region
- basal ganglia: 18 nTPM
- thalamus: 17 nTPM
- cerebral cortex: 17 nTPM
- medulla oblongata: 17 nTPM
- spinal cord: 17 nTPM
- midbrain: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.4
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transmembrane protein 230/134
- Transmembrane proteins 230/134
- Transmembrane protein 134
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM134 as an antibody target. Whether an autoantibody or antibody against TMEM134 could matter depends on whether native TMEM134 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM134 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM134 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...